Rice Hall James & Associates’s Axcelis ACLS Stock Holding History
Bought
Maintained
Sold
Other funds holding ACLS
RP
Rice Hall James & Associates's ACLS Position: Q3 2025 in Review
Rice Hall James & Associates sold out of Axcelis (ACLS) in Q3 2025, closing a stake of 31,728 shares — an estimated $2.21M sold.
Rice Hall James & Associates first reported a position in ACLS in Q4 2019 and held it in 23 quarters. The position peaked at $10.7M in Q4 2021. 361 funds tracked by Wall St. Rank hold ACLS as of Q3 2025.
- Rice Hall James & Associates reported no remaining Axcelis position as of Q3 2025 after selling out during the quarter.
- Rice Hall James & Associates sold 31,728 Axcelis shares in Q3 2025, an estimated $2.21M.
- Rice Hall James & Associates first reported a position in Axcelis in Q4 2019 and held it in 23 quarters.
- Rice Hall James & Associates's Axcelis position peaked at $10.7M in Q4 2021.
- 361 funds tracked by Wall St. Rank held Axcelis as of Q3 2025.
Based on Rice Hall James & Associates's 13F filing for Q3 2025, filed 16 Oct 2025.